The first CRISPR medicine was approved yesterday. 😲 ... And, it's in the UK!! The decision could transform the treatment of sickle-cell disease. This is the first medicine based on CRISPR technology that has been approved... ANYWHERE!! (Perhaps the only benefit of Brexit 🤣) Link in the comments!
Moxee
Staffing and Recruiting
Leeds, England 1,210 followers
🧬 Talent Acquisition should be as precise as DNA Sequencing.
About us
We help your 'Omics company to hire the brains behind your innovations. Your sourcing strategy should be as precise as your sequencing. We've witnessed the frustrations firsthand. Subpar candidates, missed opportunities, and hiring processes built with other domains in mind. ———————————————————————————————— Depending on the defined goals, Moxee will suggest: • RPO Services- for 4+ roles and project preventing hires. • Consultancy - for start-ups with embedded HR/TA who need some words of wisdom. Let us handle recruitment on their behalf, or empower them with the knowledge to do it themselves. • Search and Selection - for those extra tricky, specific hires. No hire - no fee! • Executive Search - because finding the perfect mutation for your C-Suite team is too important to leave to gut feelings, especially when our leadership teams typically lack diversity. (7.9% of executive teams in STEM are female, for example) We’re not just another Talent Agency lost in a sea of sequencing jargon. ———————-———————-———————-————————— 𝗥𝗘𝗖𝗥𝗨𝗜𝗧𝗜𝗡𝗚 𝗙𝗢𝗥: • Genomics • Proteomics • Transcriptomics • Metabolomics • Epigenomics • Pharmacogenomics • Lipidomics • Agrigenomics • NGS • Spatial Biology • Single-cell Analysis • CRISPR/Cas9 Genome Editing • Data Integration and Analysis • Bioinformatics • Biomarker Discovery • Precision Medicine • Computational Chemistry • Computational Biology ———————-———————-———————-————————— 📧 hello@moxee-search.com ———————-———————-———————-—————————
- Website
-
https://moxee-search.com/
External link for Moxee
- Industry
- Staffing and Recruiting
- Company size
- 2-10 employees
- Headquarters
- Leeds, England
- Type
- Privately Held
- Founded
- 2023
- Specialties
- life sciences, recruitment, biotechnology, genomics, proteomics, Molecular Biology, Bioinformatics, Single-Cell, Transcriptomics, Metabolomics, Epigenomics, Personalized Medicine, Precision Medicine, CRISPR, Gene Editing, Next Generation Sequencing, Computational Biology, Computational Chemistry, Spatial Biology, RNA-Seq, and Agrigenomics
Locations
-
Primary
Get directions
Redvers Close
Leeds, England LS16 6, GB
Employees at Moxee
Updates
-
Last week was HUGE for funding! 💸 👏 Here's the biotech round-up: [1] Genezen - Cell Therapy, Indiana - $18,500,000 (Venture Round) [2] Stellaromics Inc. - Multi-Omics, Massachusetts - $25,000,000 (Series A) [3] Progenx - Neuroscience, New York - $15,000,000 (Series A) [4] GENOME INSIGHT INC. - Multi-Omics, New York - $23,000,000 (Series A) [5] Gate Bioscience - Protein Degradation, California - $60,000,000 (Series A) [6] Siren Biotechnology - AAV immuno-gene therapy, California - $4,000,000 (Grant) [7] Lucid Diagnostics - Cancer Dx, New York - $5,000,000 (Venture Round) [8] Aqtual, Inc. - Precision Medicine, California - $16,000,000 (Series A) [9] Engine Biosciences - Biomarker Discovery, California - $27,000,000 (Series A) [10] Annovis Bio, Inc. - Alzheimer’s and Parkinson’s, Pennsylvania - $7,500,000 (Post) [11] Annovis Bio, Inc. - Alzheimer’s and Parkinson’s, Pennsylvania - $7,500,000 (Post) [12] 100X Bioassay - T-Cell Research, Massachusetts - $40,000 (Pre-seed) [13] BRAINBox Solutions, Inc. - mTBI, Diagnosis & Prognosis, Virginia - (Series B) [14] Granata Bio - Fertility Solutions , Massachusetts - $96,667 (Seed Round) [15] MapLight Therapeutics, Inc. - Therapeutics for CNS disorders, California - $225,000,000, (Series C) #biotech #funding
-
London-based Automata, a biotech focusing on robotic automation for life sciences labs, has raised $40 million in funding. 👏 🤑 👏 🤑 This follows a $50 million Series B round in January 2022. Investors include Dimension and A.P. Moller Holding, along with existing investors. Automata has experienced significant growth with a 150% revenue increase and a 12-fold rise in live system hours. Their LINQ automation platform offers adaptability for labs in various sectors, helping streamline processes and enhance efficiency in the face of changing scientific demands.
-
-
Adela, Inc. - a pioneer in blood testing for MRD monitoring and early cancer detection has secured $48 million in financing. 👏 This funding round involves existing investors like F-Prime Capital, OrbiMed, Deerfield Management, Decheng Capital, and RA Capital Management, as well as new investor... Labcorp! These funds will support the advancement of Adela's tech platform, including their MRD monitoring product. They also plan to develop a multi-cancer early detection product based on the same platform. Lisa Alderson, an accomplished healthcare leader, has been appointed as Adela's interim CEO. #biotech #funding #MoxeeMolecular
-
-
Fed up with the lack of Bioinformatics opportunities in Massachusetts? Lacking the opportunity to utilise your commercial acumen? Unable to manage independent projects? Frustrated with PhD's as a non-negotiable? Bioinformatician of any seniority, with experience in Mass Spec or Proteomic data sets? Send an email to hello@moxee-search.com for a link to our Calendar. 👇
-
-
Moxee is feelin' extra moxie today. Not only is it nearly the weekend... But we've been nominated in Labiotech.eu's "10 biotech recruitment companies to watch." 🔬 If you're: - operating in Multi-Omics, Gene Editing or Diagnostics - have less than 260 employees - open to change - struggling with the influx in LI applications, but still can't find "the one" Book a 30-minute discovery call here ---> https://lnkd.in/eft68WaS